NIBEC Co. Ltd Total Liabilities
NIBEC Co. Ltd total liabilities. Based on the latest financial reports, NIBEC Co. Ltd (138610) has total liabilities worth ₩16.60 Billion KRW (≈ $11.25 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 138610 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of NIBEC Co. Ltd (2014–2025)
Total liabilities of NIBEC Co. Ltd from 2014 to 2025. This chart illustrates how NIBEC Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 138610 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
NIBEC Co. Ltd Competitors by Total Liabilities
The table below lists competitors of NIBEC Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hennessy Capital Investment Corp VI
NASDAQ:HCVI
|
USA | $27.66 Million |
|
Western Carriers India Ltd
NSE:WCIL
|
India | Rs3.38 Billion |
|
SciVision Biotech Inc
TW:1786
|
Taiwan | NT$892.04 Million |
|
ReaLy Development & Construction
TWO:2596
|
Taiwan | NT$3.78 Billion |
|
Supercomnet Technologies Bhd
KLSE:0001
|
Malaysia | RM21.42 Million |
|
The Hi-Tech Gears Limited
NSE:HITECHGEAR
|
India | Rs3.17 Billion |
|
CFI Holding SA
WAR:CFI
|
Poland | zł562.03 Million |
|
Suzhou Shijing Environmental Technology Co.Ltd.
SHE:301030
|
China | CN¥8.60 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down NIBEC Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is NIBEC Co. Ltd's balance sheet.
Liquidity & Leverage Metrics
NIBEC Co. Ltd Total Liabilities Ratios Explained
NIBEC Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NIBEC Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NIBEC Co. Ltd (2014–2025)
The table below shows the annual total liabilities of NIBEC Co. Ltd from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩17.18 Billion ≈ $11.64 Million |
-43.16% |
| 2024-12-31 | ₩30.22 Billion ≈ $20.48 Million |
-20.38% |
| 2023-12-31 | ₩37.96 Billion ≈ $25.72 Million |
-1.16% |
| 2022-12-31 | ₩38.40 Billion ≈ $26.03 Million |
+48.09% |
| 2021-12-31 | ₩25.93 Billion ≈ $17.57 Million |
+22.09% |
| 2020-12-31 | ₩21.24 Billion ≈ $14.39 Million |
+154.97% |
| 2019-12-31 | ₩8.33 Billion ≈ $5.65 Million |
-29.05% |
| 2018-12-31 | ₩11.74 Billion ≈ $7.96 Million |
-12.30% |
| 2017-12-31 | ₩13.39 Billion ≈ $9.07 Million |
+1.98% |
| 2016-12-31 | ₩13.13 Billion ≈ $8.90 Million |
+52.47% |
| 2015-12-31 | ₩8.61 Billion ≈ $5.84 Million |
-5.06% |
| 2014-12-31 | ₩9.07 Billion ≈ $6.15 Million |
-- |
About NIBEC Co. Ltd
NIBEC Co., Ltd., a healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally. It offers dental ointment, peptide containing dental bone graft materials, regenerative biomaterials, tooth whitening, tooth desensitizer, herbal toothpaste, and cosmetic products. The company was founded in 2000 and is base… Read more